tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GB:CRTX Stock Latest News

CRISM Therapeutics Wins Key Japanese Patent for ChemoSeed Cancer Implant
Company AnnouncementsCRISM Therapeutics Wins Key Japanese Patent for ChemoSeed Cancer Implant
1M ago
CRISM Therapeutics Reveals Updated Major Shareholders After December Fundraising
PremiumCompany Announcements
CRISM Therapeutics Reveals Updated Major Shareholders After December Fundraising
2M ago
CRISM Therapeutics Raises Funds for Glioblastoma Trial
PremiumCompany Announcements
CRISM Therapeutics Raises Funds for Glioblastoma Trial
2M ago
CRISM Therapeutics Launches £100,000 Retail Offer to Fund Clinical Trial
PremiumCompany Announcements
CRISM Therapeutics Launches £100,000 Retail Offer to Fund Clinical Trial
3M ago
CRISM Therapeutics Secures £1 Million for Phase 2 Glioblastoma Trial
PremiumCompany Announcements
CRISM Therapeutics Secures £1 Million for Phase 2 Glioblastoma Trial
3M ago
CRISM Therapeutics Seeks FDA Orphan Drug Designation for Glioblastoma Treatment
PremiumCompany AnnouncementsCRISM Therapeutics Seeks FDA Orphan Drug Designation for Glioblastoma Treatment
4M ago
CRISM Therapeutics Advances Prostate Cancer Treatment with ChemoSeed Platform
Premium
Company Announcements
CRISM Therapeutics Advances Prostate Cancer Treatment with ChemoSeed Platform
4M ago
CRISM Therapeutics Advances ChemoSeed Technology for Cancer Treatment
Premium
Company Announcements
CRISM Therapeutics Advances ChemoSeed Technology for Cancer Treatment
5M ago
CRISM Therapeutics to Announce Interim Results and Discuss Phase 2 Glioblastoma Trial
PremiumCompany Announcements
CRISM Therapeutics to Announce Interim Results and Discuss Phase 2 Glioblastoma Trial
6M ago
CRISM Therapeutics Secures Approval for Phase 2 Glioblastoma Trial
PremiumCompany Announcements
CRISM Therapeutics Secures Approval for Phase 2 Glioblastoma Trial
6M ago
CRISM Therapeutics Secures Shareholder Backing at AGM
PremiumCompany Announcements
CRISM Therapeutics Secures Shareholder Backing at AGM
6M ago
CRISM Therapeutics Marks Milestones in Cancer Treatment Innovation
PremiumCompany Announcements
CRISM Therapeutics Marks Milestones in Cancer Treatment Innovation
6M ago
CRISM Therapeutics Begins GMP Production of ChemoSeed for Glioblastoma Trial
PremiumCompany AnnouncementsCRISM Therapeutics Begins GMP Production of ChemoSeed for Glioblastoma Trial
7M ago
CRISM Therapeutics Announces AGM and New Incentive Plan
Premium
Company Announcements
CRISM Therapeutics Announces AGM and New Incentive Plan
7M ago
CRISM Therapeutics Announces Change in Major Holdings
Premium
Company Announcements
CRISM Therapeutics Announces Change in Major Holdings
8M ago
CRISM Therapeutics Raises £874,021 to Advance Cancer Treatment Technology
PremiumCompany Announcements
CRISM Therapeutics Raises £874,021 to Advance Cancer Treatment Technology
8M ago
CRISM Therapeutics Updates Investors on Funding and Future Plans
PremiumCompany Announcements
CRISM Therapeutics Updates Investors on Funding and Future Plans
8M ago
CRISM Therapeutics Advances Glioblastoma Treatment with Phase 2 Trial
PremiumCompany Announcements
CRISM Therapeutics Advances Glioblastoma Treatment with Phase 2 Trial
8M ago
CRISM Therapeutics Launches Retail Offer to Fund ChemoSeed Development
PremiumCompany Announcements
CRISM Therapeutics Launches Retail Offer to Fund ChemoSeed Development
8M ago
CRISM Therapeutics Secures £800,000 for Glioblastoma Drug Trials
PremiumCompany AnnouncementsCRISM Therapeutics Secures £800,000 for Glioblastoma Drug Trials
8M ago
CRISM Therapeutics Reports Significant Progress and Strategic Milestones
Premium
Company Announcements
CRISM Therapeutics Reports Significant Progress and Strategic Milestones
9M ago
CRISM Therapeutics Wins Prestigious Award for ChemoSeed Research
Premium
Company Announcements
CRISM Therapeutics Wins Prestigious Award for ChemoSeed Research
9M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >